|
|
9520 South State Street Sandy, UT 84070 USA phone:801 565 8561 fax:801 565 8562
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.macromed.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Biodegradable injectable and oral polymeric drug delivery systems. |
 |
| Management |
| Thomas Bergmann, Chief Executive Officer, President and Director; Alex S. Kim, Exec VP; James E. Herrin, M.B.A., Sr VP, Finance & Corporate Development, Secretary/Treasurer; Kirk Fowers, Ph.D., Vice President, Product Development |
| |
|
|
| |
|
| Keywords |
| drug delivery, injection, oral, polymeric, microspheres, controlled release, solubilizing, DrugDelivery |
|
|
|
| Description |
|
MacroMed develops and manufactures biodegradable injectable and oral polymeric drug delivery systems. The company seeks to increase drug bioavailability and widen therapeutic indices, with secondary objectives to decrease dosing frequency and improve patient compliance |
 |
| Products / Services |
MacroMed's product platforms include the ReGel Injectable Controlled-Release System, Oligosphere Injectable Microspheres, SQZGel Oral Controlled-Release System and HySolv and ReSolv Solubilizing Systems.
|
 |
 |
|
|
|
|
|
|